UPDATED Sep 24, 2025
Discover Norwegian Pharmaceuticals & Biotech Growth Stocks that are on the OSEAX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ABS | NOK 3.40 | -5.8% | -73.8% | NOK 91.3m | n/a | PS2x | E126.9% | n/a | ||
PHO | NOK 57.30 | -3.7% | 7.7% | NOK 1.5b | NOK 82.50 | PS2.9x | E120.4% | 0% | ||
NAVA | NOK 21.70 | 3.3% | -29.3% | NOK 383.3m | NOK 36.00 | PB1.8x | E108.2% | n/a | ||
AZT | NOK 25.70 | 0.8% | 45.4% | NOK 1.3b | NOK 29.00 | PE468.3x | E79.5% | n/a | ||
NYKD | NOK 1.65 | 5.0% | -64.4% | NOK 539.5m | NOK 8.50 | PS6.8x | E-7.2% | 58.2% | ||
ZLNA | NOK 12.53 | -0.6% | n/a | NOK 251.6m | n/a | PS4834.1x | E-26.3% | n/a | ||
BGBIO | NOK 1.24 | 4.4% | -87.1% | NOK 47.5m | n/a | PS9x | E-55.7% | n/a | ||
NORD | NOK 81.00 | 0% | 95.2% | NOK 415.7m | n/a | PE3.3x | n/a | 0% | ||
EXTX | NOK 2.00 | -9.1% | -65.2% | NOK 120.2m | n/a | PB1.1x | n/a | n/a | ||
VISTN | NOK 23.20 | -2.1% | -18.9% | NOK 1.0b | n/a | PE13.5x | n/a | 5.4% | ||
CRNA | NOK 0.61 | 0.3% | -14.5% | NOK 66.8m | n/a | PE-10.1x | n/a | n/a | ||
ONCIN | NOK 1.40 | -10.8% | n/a | NOK 151.5m | n/a | PS6.8x | n/a | n/a | ||
TRMED | NOK 3.57 | -19.6% | 208.8% | NOK 1.3b | n/a | PS12601.6x | n/a | n/a | ||
PCIB | NOK 0.33 | -9.2% | -81.8% | NOK 13.1m | n/a | PS2.6x | n/a | n/a | ||
LYTIX | NOK 7.20 | 2.6% | -1.9% | NOK 491.5m | NOK 13.00 | PS808.4x | S205.0% | n/a | ||
HBC | NOK 1.75 | -3.8% | 6.1% | NOK 719.4m | n/a | PS2.7x | n/a | n/a | ||
SOFTX | NOK 0.082 | -3.8% | 331.6% | NOK 187.7m | n/a | PS17.5x | n/a | n/a |